Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Sphingosine kinase 1 participates in the activation, proliferation and survival of chronic lymphocytic leukemia cells.

Literature DB >> 28360148

Sphingosine kinase 1 participates in the activation, proliferation and survival of chronic lymphocytic leukemia cells.

María Belén Almejún^1,2, Mercedes Borge^1,3, Ana Colado¹, Esteban Enrique Elías¹, Enrique Podaza¹, Denise Risnik¹, Carlos Daniel De Brasi⁴, Carmen Stanganelli⁵, Irma Slavutsky⁶, María Cabrejo⁷, Horacio Fernández-Grecco⁷, Raimundo Fernando Bezares⁸, Santiago Cranco⁹, Rubén Ángel Burgos⁹, Julio César Sánchez-Ávalos⁹, Pablo Oppezzo¹⁰, Mirta Giordano^1,3, Romina Gamberale^11,3.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2017 PMID： 28360148 PMCID： PMC5566050 DOI： 10.3324/haematol.2017.167353

Source DB: PubMed Journal: Haematologica ISSN： 0390-6078 Impact factor: 9.941

× No keyword cloud information.

14 in total

Review 1. Nurture versus nature: the microenvironment in chronic lymphocytic leukemia.

Authors: Jan A Burger
Journal: Hematology Am Soc Hematol Educ Program Date: 2011

2. The expression of sphingosine-1 phosphate receptor-1 in chronic lymphocytic leukemia cells is impaired by tumor microenvironmental signals and enhanced by piceatannol and R406.

Authors: Mercedes Borge; Federico Remes Lenicov; Paula R Nannini; María M de los Ríos Alicandú; Enrique Podaza; Ana Ceballos; Horacio Fernández Grecco; María Cabrejo; Raimundo F Bezares; Pablo E Morande; Pablo Oppezzo; Mirta Giordano; Romina Gamberale
Journal: J Immunol Date: 2014-08-15 Impact factor: 5.422

3. SphK1 inhibitor II (SKI-II) inhibits acute myelogenous leukemia cell growth in vitro and in vivo.

Authors: Li Yang; Wei Weng; Zhi-Xin Sun; Xian-Jie Fu; Jun Ma; Wen-Fang Zhuang
Journal: Biochem Biophys Res Commun Date: 2015-03-28 Impact factor: 3.575

4. Lysosomotropic agents selectively target chronic lymphocytic leukemia cells due to altered sphingolipid metabolism.

Authors: R F Dielschneider; H Eisenstat; S Mi; J M Curtis; W Xiao; J B Johnston; S B Gibson
Journal: Leukemia Date: 2015-02-23 Impact factor: 11.528

Review 5. The outs and the ins of sphingosine-1-phosphate in immunity.

Authors: Sarah Spiegel; Sheldon Milstien
Journal: Nat Rev Immunol Date: 2011-05-06 Impact factor: 53.106

Review 6. Revisiting the sphingolipid rheostat: Evolving concepts in cancer therapy.

Authors: Jason Newton; Santiago Lima; Michael Maceyka; Sarah Spiegel
Journal: Exp Cell Res Date: 2015-03-11 Impact factor: 3.905

7. The Sphingosine-1-Phosphate Modulator FTY720 Targets Multiple Myeloma via the CXCR4/CXCL12 Pathway.

Authors: Katia Beider; Evgenia Rosenberg; Hanna Bitner; Avichai Shimoni; Merav Leiba; Maya Koren-Michowitz; Elena Ribakovsky; Shiri Klein; Devorah Olam; Lola Weiss; Hanna Wald; Michal Abraham; Eithan Galun; Amnon Peled; Arnon Nagler
Journal: Clin Cancer Res Date: 2016-10-03 Impact factor: 12.531

Review 8. Therapeutic potential of targeting sphingosine kinases and sphingosine 1-phosphate in hematological malignancies.

Authors: C Evangelisti; C Evangelisti; F Buontempo; A Lonetti; E Orsini; F Chiarini; J T Barata; S Pyne; N J Pyne; A M Martelli
Journal: Leukemia Date: 2016-07-27 Impact factor: 11.528

9. Sphingosine kinase inhibitors decrease viability and induce cell death in natural killer-large granular lymphocyte leukemia.

Authors: Francis R LeBlanc; Xin Liu; Jeremy Hengst; Todd Fox; Valerie Calvert; Emanuel F Petricoin; Jong Yun; David J Feith; Thomas P Loughran
Journal: Cancer Biol Ther Date: 2015 Impact factor: 4.742